Lv4
406 积分 2023-04-19 加入
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
16天前
已完结
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals
1个月前
已完结
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer
2个月前
已完结
The expression of VEGF and Dll4/Notch pathway molecules in ovarian cancer
2个月前
已完结
Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma
2个月前
已完结
The present and future of bispecific antibodies for cancer therapy
2个月前
已完结
The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma
2个月前
已完结
Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity
2个月前
已完结
Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma
2个月前
已完结
皖公网安备34019202002308
